These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8597884

  • 1. Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.
    Kamada H, Takaoka Y, Kitagaki K, Nagai H.
    Inflamm Res; 1995 Nov; 44(11):491-8. PubMed ID: 8597884
    [Abstract] [Full Text] [Related]

  • 2. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R, Shibata T, De Kossodo S, Izui S.
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [Abstract] [Full Text] [Related]

  • 3. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
    Miyawaki S, Nakamura Y, Takeshita T, Yoshida H, Shibata Y, Mitsuoka S.
    Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
    [Abstract] [Full Text] [Related]

  • 4. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.
    Suzuka H, Yoshifusa H, Nakamura Y, Miyawaki S, Shibata Y.
    Autoimmunity; 1993 Jun; 14(4):275-82. PubMed ID: 8347770
    [Abstract] [Full Text] [Related]

  • 5. Comparison of immunological effects of cholera toxin on autoimmune MRL/lpr and BXSB mice.
    Zhou NN, Nakai S, Oka M, Nagasawa H, Himeno K.
    Microbiol Immunol; 1992 Jun; 36(7):745-56. PubMed ID: 1406377
    [Abstract] [Full Text] [Related]

  • 6. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice.
    Palacios R.
    Eur J Immunol; 1984 Jul 01; 14(7):599-605. PubMed ID: 6430708
    [Abstract] [Full Text] [Related]

  • 8. Thymic microenvironmental abnormalities in MRL/MP-lpr/lpr, BXSB/MpJ Yaa and C3H HeJ-gld/gld mice.
    Takeoka Y, Yoshida SH, Van de Water J, Boyd R, Suehiro S, Ansari AA, Gershwin ME.
    J Autoimmun; 1995 Apr 01; 8(2):145-61. PubMed ID: 7612145
    [Abstract] [Full Text] [Related]

  • 9. Macrophage I-A/I-E expression and macrophage-stimulating lymphokines in murine lupus.
    Kofler R, Schreiber RD, Dixon FJ, Theofilopoulos AN.
    Cell Immunol; 1984 Aug 01; 87(1):92-100. PubMed ID: 6204780
    [Abstract] [Full Text] [Related]

  • 10. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
    Kushida T, Inaba M, Takeuchi K, Sugiura K, Ogawa R, Ikehara S.
    Blood; 2000 Mar 01; 95(5):1862-8. PubMed ID: 10688849
    [Abstract] [Full Text] [Related]

  • 11. Combined treatment of autoimmune MRL/MP-lpr/lpr mice with a herbal medicine, Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to) plus suboptimal dosage of prednisolone.
    Zhou NN, Nakai S, Kawakita T, Oka M, Nagasawa H, Himeno K, Nomoto K.
    Int J Immunopharmacol; 1994 Oct 01; 16(10):845-54. PubMed ID: 7843856
    [Abstract] [Full Text] [Related]

  • 12. Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action.
    Xu X, Gong H, Blinder L, Shen J, Williams JW, Chong AS.
    J Pharmacol Exp Ther; 1997 Nov 01; 283(2):869-75. PubMed ID: 9353408
    [Abstract] [Full Text] [Related]

  • 13. Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration.
    Nagata N, Nakagawa T, Hosaka N, Ikehara S.
    Immunobiology; 1992 Nov 01; 186(5):339-50. PubMed ID: 1286875
    [Abstract] [Full Text] [Related]

  • 14. Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation.
    Carlsten H, Tarkowski A.
    Scand J Immunol; 1989 Oct 01; 30(4):457-62. PubMed ID: 2814366
    [Abstract] [Full Text] [Related]

  • 15. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.
    Kanai Y, Takeda O, Miura K, Amagai M, Kaneko T, Kubota T, Kanai Y, Tanuma S, Kurosawa Y.
    Immunol Lett; 1995 Feb 01; 45(1-2):35-42. PubMed ID: 7622185
    [Abstract] [Full Text] [Related]

  • 16. 5-Azacytidine inhibits the lpr gene-induced lymphadenopathy and acceleration of lupus-like syndrome in MRL/MpJ-lpr/lpr mice.
    Yoshida H, Yoshida M, Merino R, Shibata T, Izui S.
    Eur J Immunol; 1990 Sep 01; 20(9):1989-93. PubMed ID: 1698637
    [Abstract] [Full Text] [Related]

  • 17. BXSB/MpJ-Yaa mice develop autoimmune dacryoadenitis with the appearance of inflammatory cell marker messenger RNAs in the lacrimal fluid.
    Kosenda K, Ichii O, Otsuka S, Hashimoto Y, Kon Y.
    Clin Exp Ophthalmol; 2013 Nov 01; 41(8):788-97. PubMed ID: 23433092
    [Abstract] [Full Text] [Related]

  • 18. Abnormal behavior of gamma-committed B lymphocytes probed by a lymphocyte blastogenesis inhibitory factor in autoimmune MRL mice.
    Sugimura K, Wada Y, Kimura T, Ohno T, Kobayashi S, Azuma I.
    Eur J Immunol; 1990 Sep 01; 20(9):1899-904. PubMed ID: 2209696
    [Abstract] [Full Text] [Related]

  • 19. Age-associated increase in interleukin 6 in MRL/lpr mice.
    Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, Kishimoto T.
    Int Immunol; 1991 Mar 01; 3(3):273-8. PubMed ID: 2049341
    [Abstract] [Full Text] [Related]

  • 20. Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice.
    Farrell M, Sakić B, Szechtman H, Denburg JA.
    Lupus; 1997 Mar 01; 6(3):268-74. PubMed ID: 9104735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.